Risk of new‐onset diabetes after androgen deprivation therapy for prostate cancer in the Asian population 亚洲前列腺癌患者接受雄激素去势治疗后患糖尿病的风险分析

Publisher： John Wiley & Sons Inc

E-ISSN： 1753-0407|7|5|672-680

ISSN： 1753-0393

Source： JOURNAL OF DIABETES, Vol.7, Iss.5, 2015-09, pp. : 672-680

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risk of acute myocardial infarction after androgen‐deprivation therapy for prostate cancer in a Chinese population

By  

BJU INTERNATIONAL, Vol. 116, Iss. 3, 2015-09 ,pp. : 382-387

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk for new-onset diabetes mellitus after transplantation: implication of advanced age and immunosuppressive therapy

By Salifu Moro O   Markell Mariana S   Haria Dhiren M   Stratilatova Mariya   Meghani Sheni   Hong Joon   Sumrani Nabil   Distant Dale   Friedman Eli  

Therapy, Vol. 2, Iss. 4, 2005-07 ,pp. : 597-602

Future Medicine

Access to resources Recommend Favorite

Risk of new‐onset type II diabetes after appendicectomy

By  

BRITISH JOURNAL OF SURGERY, Vol. 102, Iss. 10, 2015-09 ,pp. : 1267-1271

John Wiley & Sons Inc

Access to resources Recommend Favorite

Docetaxel, bevacizumab, and androgen deprivation therapy for biochemical disease recurrence after definitive local therapy for prostate cancer

By  

CANCER, Vol. 121, Iss. 15, 2015-08 ,pp. : 2603-2611

John Wiley & Sons Inc

Access to resources Recommend Favorite

Androgen deprivation therapy and the risk of death from prostate cancer among men with favorable or unfavorable intermediate‐risk disease

By  

CANCER, Vol. 121, Iss. 16, 2015-08 ,pp. : 2713-2719

John Wiley & Sons Inc

Access to resources Recommend Favorite